Umberto Tirelli Selected Research

Highly Active Antiretroviral Therapy (HAART)

07/2008	FOLFOX-4 regimen with concomitant highly active antiretroviral therapy in metastatic colorectal cancer HIV-infected patients: a report of five cases and review of the literature.
07/2008	Bevacizumab plus irinotecan-, fluorouracil-, and leucovorin-based chemotherapy with concomitant HAART in an HIV-positive patient with metastatic colorectal cancer.
05/2006	Don't deny liver transplantation to HIV patients with hepatocellular carcinoma in the highly active antiretroviral therapy era.
11/2005	Patients with HIV with Burkitt's lymphoma have a worse outcome than those with diffuse large-cell lymphoma also in the highly active antiretroviral therapy era.
04/2005	Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma (KS): implications for the design of therapeutic trials in patients with advanced symptomatic KS.
04/2005	Characterization of immunologic and virological parameters in HIV-infected patients with primary effusion lymphoma during antiblastic therapy and highly active antiretroviral therapy.
12/2003	Virological efficacy in HIV-infected patients affected by non-Hodgkin lymphoma, treated with antiblastic chemotherapy and highly active antiretroviral therapy.
12/2003	High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy.
12/2003	Improvement of systemic human immunodeficiency virus-related non-Hodgkin lymphoma outcome in the era of highly active antiretroviral therapy.
12/2003	Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma.
09/2003	Impact of concomitant antiblastic chemotherapy and highly active antiretroviral therapy on human immunodeficiency virus (HIV) viremia and genotyping in HIV-infected patients with non-Hodgkin lymphoma.
08/2003	AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals.
09/2002	Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection.

Articles by Research Topic

Disease

12	Non-Hodgkin Lymphoma (Lymphosarcoma) 08/2008 - 01/2003
6	Acquired Immunodeficiency Syndrome (AIDS) 05/2006 - 07/2002
5	Hodgkin Disease (Hodgkin's Disease) 12/2007 - 09/2002
4	Small Cell Carcinoma 05/2008 - 10/2005
4	Kaposi Sarcoma (Kaposi's Sarcoma) 11/2005 - 08/2003
2	Colorectal Neoplasms (Colorectal Cancer) 07/2008 - 07/2008
2	Lung Neoplasms (Lung Cancer) 12/2007 - 10/2005
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell) 11/2005 - 07/2002
2	Lymphoma (Lymphomas) 09/2005 - 12/2003
2	Infection 07/2005 - 09/2004
2	Carcinoma (Carcinomatosis) 05/2005 - 01/2003
2	HIV Infections (HIV Infection) 01/2003 - 09/2002
1	Hepatocellular Carcinoma (Hepatoma) 05/2006
1	Burkitt Lymphoma (Burkitt's Lymphoma) 11/2005
1	Cryoglobulinemia 05/2005
1	Primary Effusion Lymphoma 04/2005
1	Viremia 09/2003
1	Neoplasms (Cancer) 08/2003

Drug/Important Bio-Agent (IBA)

4	rituximab (Mabthera)FDA Link 02/2007 - 01/2003
2	irinotecan (Camptosar)FDA LinkGeneric 07/2008 - 11/2005
2	gemcitabine FDA Link 01/2007 - 02/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2006 - 03/2005
2	Ribavirin (Virazole)FDA LinkGeneric 07/2005 - 05/2005
1	Immunoglobulins (Immunoglobulin)IBA 08/2008
1	Fluorouracil (Carac)FDA LinkGeneric 07/2008
1	bevacizumab FDA Link 07/2008
1	Leucovorin (Folinic Acid)FDA LinkGeneric 07/2008
1	pemetrexed (MTA)FDA Link 05/2008
1	gefitinib (Iressa)FDA Link 01/2007
1	Ifosfamide FDA LinkGeneric 01/2007
1	vinorelbine (Navelbine)FDA LinkGeneric 01/2007
1	Carboplatin (JM8)FDA LinkGeneric 02/2006
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2006
1	InterferonsIBA 07/2005
1	Interferon Alfa-2b (Interferon Alfa 2b)FDA Link 05/2005
1	Protease Inhibitors (Protease Inhibitor)IBA 04/2005
1	Etoposide (VP 16)FDA LinkGeneric 03/2005
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2005
1	PerforinIBA 01/2003
1	Interferon-gamma (Interferon, gamma)IBA 01/2003
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2002
1	Cyclin-Dependent Kinase Inhibitor p27IBA 07/2002

Therapy/Procedure

13	Highly Active Antiretroviral Therapy (HAART) 07/2008 - 09/2002
13	Drug Therapy (Chemotherapy) 07/2008 - 01/2003
1	Homologous Transplantation (Allograft) 04/2007
1	Liver Transplantation 05/2006
1	Aftercare (After-Treatment) 07/2005
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 09/2004
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 12/2003